AbbVie’s Skyrizi and Rinvoq were practically unshakeable atop the monthly TV drug ad spending rankings, ultimately leading ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.

Regulators in the US and Europe have started to review Novartis' biosimilar version of ... and Crohn's disease in the US, ad highly-active RRMS in the EU. The looming competition piles further ...

Medical marketers, ad agencies, physicians and pharma executives gathered for MM+M’s annual Transform conference, held at One ...

President Trump’s newly announced tariff policy has done more than just push the stock markets deeper into correction territory — the sudden ...

Read the latest crime and court news from Dundalk, Louth and the surrounding areas, Co Louth Please allow ads as they help ...

A Swiss drug giant has gotten the message from President Trump’s tariff threats. Novartis said Thursday it will spend $23 ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Novartis will substantially expand its U.S. footprint, announcing Thursday plans to spend $23 billion ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...

North Carolina economic development officials have terminated an economic incentives agreement for Novartis Gene Therapies, which hasn’t met hiring targets tied to a package that promised up to ...

Pharma warns EU of US exodus due to tariffs, risking billions in investment, demands policy change for competitiveness.